open access

Vol 73, No 4 (2023)
Pictures in Oncology
Published online: 2023-07-04
Get Citation

Rare skin tumor – primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

Damian W. Trzos1, Wojciech M. Wysocki213
·
Nowotwory. Journal of Oncology 2023;73(4):256.
Affiliations
  1. Department of General and Oncological Surgery, 5th Military Clinical Hospital in Krakow, Krakow, Poland
  2. Chair of Surgery, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
  3. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

open access

Vol 73, No 4 (2023)
Pictures in oncology
Published online: 2023-07-04

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Rare skin tumor – primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

Journal

Nowotwory. Journal of Oncology

Issue

Vol 73, No 4 (2023)

Article type

Pictures in Oncology

Pages

256

Published online

2023-07-04

Page views

448

Article views/downloads

222

DOI

10.5603/NJO.a2023.0030

Bibliographic record

Nowotwory. Journal of Oncology 2023;73(4):256.

Authors

Damian W. Trzos
Wojciech M. Wysocki

References (3)
  1. Besch-Stokes JG, Costello CM, Severson KJ, et al. Primary cutaneous CD4 small/medium T-cell lymphoproliferative disorder: Diagnosis and management. J Am Acad Dermatol. 2022; 86(5): 1167–1169.
  2. Gru AA, Wick MR, Eid M. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018; 37(1): 39–48.
  3. Surmanowicz P, Doherty S, Sivanand A, et al. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series. Dermatology. 2021; 237(4): 618–628.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl